Liver-resident CD8 + T cells are highly motile cells that patrol the vasculature and provide protection against liver pathogens. A key question is: How can these liver CD8 + T cells be simultaneously present in the circulation and tissue-resident? Because liver-resident T cells do not express CD103-a key integrin for T cell residence in epithelial tissues-we investigated other candidate adhesion molecules. Using intravital imaging, we found that CD8 + T cell patrolling in the hepatic sinusoids is dependent on LFA-1-ICAM-1 (intercellular adhesion molecule-1) interactions. Liver-resident CD8 + T cells up-regulate LFA-1 compared with effector memory cells, presumably to facilitate this behavior. Last, we found that LFA-1-deficient CD8 + T cells failed to form substantial liver-resident memory populations after Plasmodium immunization or lymphocytic choriomeningitis virus infection. Collectively, our results demonstrate that it is adhesion through LFA-1 that allows liver-resident memory CD8 + T cells to patrol and remain in the hepatic sinusoids.
INTRODUCTION

CD8
+ T cells play critical roles in protection against infectious diseases and cancers. One problem that T cells must overcome is that the number of infected cells can represent a tiny fraction of cells in the body. To achieve efficient tissue surveillance, specialized populations of CD8 + T cells that patrol different niches develop after priming. The first populations to be defined, on the basis of the expression of CD62L and CCR7, were central and effector memory CD8 + T cells (1) . More recently, populations of tissue-resident memory (T RM ) cells have been identified in numerous tissues-especially barrier tissues-such as the skin, lung, gut, and female reproductive tract (2) (3) (4) (5) (6) . Such cells are strictly defined by their inability to recirculate from their tissue of residence, though they are frequently identified by the expression of CD69 and the integrin CD103 (2, 3, 6) . Intravital imaging studies have revealed that CD8 + T RM cells in the skin are largely sessile cells that may act as sentinels against invading pathogens (7) . This is consistent with the finding that these cells function as the first line of defense in peripheral tissues, able to recruit other cells to the immune response (8) .
Given that the liver is the target organ of important pathogens, including hepatitis B virus, hepatitis C virus, and Plasmodium, several recent studies have begun to characterize T RM cells in this organ (5, 9, 10) . Although the liver was previously thought of as a "graveyard" for CD8 + T cells, it is now clear that it harbors large numbers of memory CD8 + T cells capable of protecting against pathogen challenge (11, 12) . We have recently shown that the formation of robust CD69 + CD8 + T cell populations is essential for effective protection against Plasmodium (malaria) liver stages (9) . On the basis of parabiosis studies, these CD69 + cells in the liver have been defined as a resident population that does not recirculate within 2 to 3 months (5, 9) . Liver T RM cells also share with epithelial T RM cells a common gene expression signature dependent on the expression of the transcription factors Hobit and Blimp1 (9, 10) . However, liver CD8 + T cells have some distinct features compared with epithelial T RM cells: Most liver T RM cells are present in the circulation, as revealed by in vivo antibody labeling experiments (5, 9) . Intravital imaging has further shown that liver T RM cells display motile patrolling behavior in the hepatic sinusoids (9) .
A critical question therefore is: What are the molecular interactions that retain CD8 + T cells in the liver and facilitate their patrolling behavior? Liver T RM cells do not express high levels of CD103 (9, 10) , an integrin that is required for T RM cells to be retained in many epithelial tissues (13) . On the other hand, a variety of other adhesion molecules have been implicated in the migration of CD8 + T cells to the liver. The initial trapping of CD8 + T cells in the liver appears to be mediated by interactions between CD8 + T cells and platelets bound to the endothelium via CD44, rather than selectin-mediated rolling interactions (14) . Some studies have suggested that intercellular adhesion molecule-1 (ICAM-1) is required for the retention of naive and activated CD8 + T cells in the liver but only in the presence of antigen (15, 16) . Although the ICAM-1 ligand LFA-1 has been found to be critical for natural killer T (NKT) cell retention in the liver (17, 18) , this canonical adhesion molecule has been regarded as dispensable for the intrahepatic retention of activated CD8 + T cells (14, 17) .
Here, we investigated the roles of a range of adhesion molecules in the intrahepatic migration of effector and memory CD8 + T cells using intravital imaging. We found that, unexpectedly, ICAM-1-LFA-1 interactions are indeed important for the movement of activated CD8 + T cells in the liver. Further analysis revealed that LFA-1 is highly expressed specifically on liver T RM cells and that its absence results in their inability to establish residence in the liver. Our data thus reveal an unexpected role for the adhesion molecule LFA-1, rather than CD103, in the retention of liver T RM cells and highlight the distinct adhesion molecule requirements for memory T cells that patrol vascular, rather than barrier, tissues.
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RESULTS
Activated CD8
+ T cells use LFA-1-ICAM-1 interactions to patrol the liver Previous studies have shown that CD8 + T cells migrate in the hepatic sinusoids with a characteristic patrolling behavior that facilitates their ability to scan the liver and find pathogens, such as Plasmodium and hepatitis B virus (14, 19) . We used antibody blockade to investigate the roles of ICAM-1, VCAM-1 (vascular cell adhesion molecule-1), and CD44 on the patrolling behavior of transferred in vitro activated CD8 + T cells. These molecules have been proposed to have roles in the intrahepatic accumulation of CD8 + T cells, though with the exception of CD44, their roles in migratory behavior within the liver have not been studied (14, 16) . We also transferred cells to  2 -microglobulindeficient recipients to examine the role of major histocompatibility complex class I interactions, which have also been suggested to be important for CD8 + T cell adhesion in the liver (20) . We subsequently examined the migration of the activated CD8 + T cells in the liver by time-lapse multiphoton microscopy (movie S1). Unexpectedly, only ICAM-1 blockade had any effect on CD8 + T cell movement, with cells in treated mice moving more slowly and spending more time arrested than cells in control mice (Fig. 1, A and B) , suggesting that ICAM-1 and its ligands might be important for CD8 + T cell patrolling of the liver. In contrast, antibodies to other adhesion molecules as well as rat immunoglobulin G2b (IgG2b) isotype control antibodies had no effect on migration of CD8 + T cells ( fig. S1 ). The reduction in T cell speed seen in anti-ICAM-1-treated mice is consistent with previous in vitro studies that show that ICAM-1 is required for the crawling motility of lymphocytes as well as their adhesion (21) .
Blood
Given that ICAM-1 is highly expressed on the surface of liver sinusoidal endothelial cells and hepatocytes (14, 20) , we hypothesized that T cells were crawling on these surfaces using the integrin LFA-1 that is highly expressed on CD8 + T cells. LFA-1 is composed of integrin -L (ITGAL; CD11a) combined with integrin -2 (CD18). To further investigate a possible role of LFA-1 in T cell migration in the liver, we used a mouse line carrying a Cys77Phe mutation caused by a G>T change in Exon 3 of the Itgal gene (Chromosome 7, position 127299608). This mutation causes a complete lack of ITGAL on the cell surface (fig. S2A) ; accordingly, we designate them Itgal −/− for simplicity. It is likely that Cys 77 forms disulfide bonds and that the mutation destabilizes the integrin structure. These mice were identified from an N-ethyl-N-nitrosourea (ENU) mutagenesis screen for immune phenotypes in the blood (22) because they have an elevated proportion of NKT cells in the blood ( fig. S2B ). This may be explained by the fact that LFA-1 has been shown to be important for the intrahepatic retention of NKT cells (18) . Closer analysis of our Itgal −/− mice revealed that they also have elevated CD8 + T cells in the blood, particularly CD44 hi -activated CD8 + T cells ( fig. S2B ). To investigate the effect of loss of ITGAL on CD8 + T cell migration in the liver, we activated Itgal −/− OT-I cells in vitro and cotransferred them to mice with similarly activated but differentially labeled wildtype (WT) OT-I cells. Migration in the liver was then assessed by multiphoton microscopy (movie S2 and Fig. 1C ). In agreement with our ICAM-1 blockade data, Itgal −/− cells did not display patrolling behavior; rather, they spent large amounts of time arrested and moved with slower average speeds than WT cells (Fig. 1D) . The Itgal −/− and WT cells showed similar expression of activation markers and other  2 integrins, suggesting that the reduced migration was not due to inadequate priming of Itgal −/− cells, resulting in the expression of different adhesion molecules ( fig. S3 ). We further used flow cytometry to quantify the accumulation of cells in the liver and other organs in mice that received equal numbers of WT and Itgal −/− cells. In the liver and lungs, Itgal −/− cells constituted <20% of the cells recovered from these mice; in contrast, Itgal −/− cells formed the major proportion of cells recovered from the spleen, blood, and lymph nodes (Fig. 1, E and F) . One hypothesis is that the spleen and lymph nodes act as a sink for the Itgal −/− cells; however, our intravital imaging data (Fig. 1, B and C) and our finding that there are also elevated numbers of Itgal −/− cells circulating in the blood suggest that this is not the case. Rather, our data suggest that LFA-1 is important for the retention of activated CD8 + T cells in the liver and lungs.
LFA-1 is required for efficient CD8 + T cell-mediated protection against malaria
We next wanted to determine whether the lack of patrolling cells in the liver would affect protection against the Plasmodium parasite. Although CD8 + T cells are capable of killing parasites in the liver (19), it is not known whether the cells conferring protection are those circulating in the blood or those migrating in the sinusoids. Given the results of the previous experiment, in which the Itgal −/− cells are enriched in the blood and WT cells are enriched in the liver, we were able to test this by transferring activated Itgal −/− or WT OT-I cells to mice before challenge with Plasmodium berghei CS 5M parasites that express the SIINFEKL epitope within the immunodominant circumsporozoite (CS) protein (23) . We found that the parasite burden was significantly greater in mice that received the Itgal −/− cells than in those that received WT cells ( Fig. 2A) . Although a component of this impaired protection by Itgal −/− cells may be attributed to a defect in cytotoxicity (Fig. 2B ), we also observed by intravital microscopy that WT OT-I cells were better able to associate with and cluster around P. berghei . Thus, our data are consistent with the hypothesis that LFA-1-mediated patrolling of the liver is required for efficient immune surveillance, though we cannot exclude the possibility that LFA-1 is also important for CD8 + T cell killing of infected cells.
Memory T cells in the liver adopt a characteristic patrolling behavior in the hepatic sinusoids
We next wanted to determine whether the migratory behavior that we observed in in vitro activated cells reflects that of in vivo primed cells. Accordingly, we immunized mice that had received naïve green fluorescent protein-expressing (GFP + ) OT-I cells with P. berghei CS 5M sporozoites. The livers of mice were then imaged at effector (1 week) and memory (4 weeks) time points after immunization (Fig. 3, A and B, and movies S3 and S4). At effector time points, the behavior of donor T cells in the liver was different from that observed with in vitro activated cells. There were many rounded-up cells and cells moving with the blood flow. To capture these rapidly moving cells, we modified our imaging protocol and made high framerate movies (3 frames/s) using the resonant scanner on our microscope. Math ematically, we were then able to distinguish three migratory phenotypes among the GFP + cells using the parameters of cell speed and polarity (Fig. 3C) . We designated the first population as "flowing" cells; these cells moved rapidly (speed, >25 m/min; median, 208 m/min) in the blood though sometimes they briefly arrested on the walls of the sinusoids. Among the nonflowing cells moving at <25 m/s, we observed a population of "rounded" cells, which we formally defined as having a polarity of <1.5; these cells were often arrested but sometimes detached (median speed, 5.8 m/min). Last, we were able to observe some "patrolling" cells that we defined by their higher polarity (>1.5). Overall, these cells moved similarly to in vitro activated cells, though they had a higher median speed (9.5 m/s). At the memory time point, a notably different picture was seen, with a substantial increase in the number of patrolling cells that increased from <5% of cells 1 week after immunization to >50% of the total cells at 4 weeks after immunization (Fig. 3D) . We further found that ICAM-1 blockade reduced the speed and increased the arrest coefficient of memory CD8 + T cells in the liver (Fig. 3E ), suggesting that these cells, like in vitro activated effectors, use LFA-1-ICAM-1 interactions for their patrolling behavior.
Liver-resident memory CD8
+ T cells express exceptionally high levels of LFA-1 Given that LFA-1 was found to be important for migration of in vitro activated CD8 + T cells in the liver, we speculated that the formation of a patrolling memory population in the liver might be associated with an increase in the expression of LFA-1 (ITGAL; CD11a) on CD8 + T cells. We examined the phenotypes of OT-I cells in the spleen, lymph node, and livers of mice at 1, 2, and 4 weeks after immunization with P. berghei CS 5M sporozoites ( T cells in the spleen at all time points; however, at 2 and 4 weeks after immunization, we observed a distinct population of CD11a hi cells in the liver (Fig. 4, A and B, and fig. S4 ). This population did not appear to be present in the lymph nodes and spleen, which is consistent with our previous data (Fig. 1, E and F) , suggesting that LFA-1 is dispensable for homing to these organs. We were further interested in knowing the broader phenotype of the CD11a hi population, particularly whether they might correspond to liver T RM CD8 + T cells. We found that, indeed, CD11a hi cells were almost exclusively CD69 + KLRG1 − CXCR3 + (Fig. 5, A and B) , a typical profile for liver T RM cells (9, 10) . We also found that the CD11a hi cells in the liver did not express high levels of CD103 (Fig. 5B) , whereas intravenous injection of fluorescein isothiocyanate-labeled anti-CD8a antibody revealed these cells to be in the circulation ( fig. S5A ), which is also in agreement with previous descriptions of liver T RM cells (5, 9, 10) .
To determine whether this CD11a hi population is unique to the liver or may be seen in other tissues, we examined the spleen, lymph node, blood, skin, and lungs of mice immunized with sporozoites. Although we were unable to detect antigen-specific cells in the skin of sporozoite immunized mice, we were able to detect CD11a hi CD69 + cells in the lungs of immunized mice (Fig. 5, C and D) . However, these lung CD11a hi cells were unlikely to be T RM cells because lung T RM cells express CD103 and are not labeled by intravenously injected antibody (IVAb) (6, 24) , whereas the CD11a hi cells that we observed were CD103 − and IVAb + ( fig. S5 ). To determine whether the elevated expression of LFA-1 on liver CD8 + T cells was specific to Plasmodium immunization, we also examined CD11a expression on NP396 Tetramer + cells after intraperitoneal infection with lymphocytic chorio meningitis virus (LCMV) Armstrong. Similar to our results with sporozoites, we identified a CD11a hi population in the liver that corresponded to previously defined liver T RM populations, as they are CD69 + CD103 − KLRG1 − ( fig. S6 , A to C). We also identified a similar population of CD11a hi CD69 + KLRG1 − cells in the lung after LCMV infection ( fig. S6D) . Although a modest proportion (~20%) of Tetramer + cells were IVAb − in this case, we did not detect any appreciable CD103 expression ( fig. S6D ), which is in agreement with previous observations that show that intraperitoneal LCMV infection does not induce lung T RM cells (25, 26) . Independently, a distinct population of CD11a hi cells in the liver has been observed previously after vesicular stomatitis virus infection (27) , though this observation was not followed up. Last, we analyzed NKT cells as the other liver-resident lymphocyte subset and found that NKT cells also have an identical CD11a hi CD69 + KLRG1 − phenotype to liver T RM cells ( fig. S7 ).
LFA-1 is required for the retention of T RM cells in the liver
To determine whether LFA-1 is required for the intrahepatic retention of CD8 + T cells, we first made mixed bone marrow chimeras containing CD45. S9 , B and C), indicating that ITGAL is required for its residency. In contrast, when we examined CD69 − CD8 + T cells in the liver, we found that these were not dependent on ITGAL for retention in the liver (fig. S9, B and C) . A similar analysis of the lung CD69 + and CD69 − cell populations revealed that, in contrast to the liver, ITGAL is critical for the accumulation of both these populations in the lung ( fig. S9, D to F) .
To determine whether LFA-1 is required for the formation of antigenspecific liver T RM cell populations after immunization, we cotransferred GFP + Itgal −/− and WT CD45.1 + OT-I cells to CD45.2 + mice before immunization with P. berghei CS 5M sporozoites (Fig. 7A) . At 1 week after infection, we observed that the WT cells outnumbered the Itgal −/− cells in both the liver and spleen by about 30:1 (Fig. 7B) , a result consistent with the priming defect previously reported for Itgal −/− cells (28) . However, whereas this ratio remained constant at 4 weeks after immunization in the spleen, the Itgal −/− cells were now outnumbered by about 60:1 in the liver, suggesting that these LFA-1-deficient cells have a specific defect in forming memory populations in this organ (Fig. 7C) .
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Examination of the phenotypes of the cells revealed that the difference between the spleen and liver was largely driven by the relative proportions of CD69 + KLRG1 − (T RM ) cells (Fig. 7D ). This population typically made up ~30% of the WT OT-I cells in the liver but accounted for only ~10% of the Itgal −/− cells in the same mouse (Fig. 7E ). These cells may not be lost altogether but may enter the general circulation, because the situation was reversed in the spleen, with a higher proportion of T RM phenotype cells among the Itgal −/− OT-I cells compared with the WT OT-I cells (Fig. 7E) . As a result of this, the ratio of WT to Itgal −/− OT-I T RM cells was 120:1 in the livers of immunized mice but was only 8:1 in the spleens (Fig. 7F) . Nonetheless, the ratio of Itgal −/− to WT non-T RM cells was still significantly lower in the liver compared with the spleen, suggesting that activated non-T RM cells may still use ITGAL to accumulate in the liver.
We also investigated the ratio of Itgal −/− to WT OT-I cells in other organs in this experiment (Fig. 7G ). In agreement with our bone marrow chimera data, lung OT-I cells had an even stronger requirement for ITGAL than liver OT-I cells, with Itgal −/− cells being outnumbered by about 120:1 by WT cells. In contrast, Itgal −/− cells were only outnumbered by about 8:1 by WT OT-I cells in the lymph nodes. This suggests that some Itgal −/− cells may accumulate in lymph nodes, though the proportion of OT-I cells in the lymph nodes was very small (fig. S5) .
Last, we were concerned that our data might be biased by the poor priming of the LFA-1-deficient cells by Plasmodium, especially in a competitive environment. Accordingly, we infected Itgal −/− mice and their WT littermates with LCMV Armstrong and measured the formation of antigen-specific T cell responses using NP396 tetramers. In this infection model, there was no detectable defect in priming in the Itgal −/− mice because similar percentages of Tetramer + cells were seen in the blood 1 week after immunization (Fig. 7A) . Moreover, 4 weeks after immunization, there were similar proportions and numbers of Tetramer + cells between the Itgal −/− and littermate mice in both the spleen and liver (Fig. 7, B and C) . However, whereas robust populations of antigenspecific CD69 + KLRG1 − T RM cells were formed in livers of littermate control mice, few were seen in Itgal −/− mice (Fig. 7, D and E) . Similar to our results with Plasmodium immunization, there was a ~2-fold increase in the average numbers of CD69 + KLRG1 − cells in the spleens of Itgal −/− compared with littermates, suggesting that these cells may accumulate in secondary lymphoid organs if they are unable to be retained in the liver, though this did not reach statistical significance when correction was made for multiple comparisons. Collectively, these data from our bone marrow chimeras and two distinct models of infection suggest that LFA-1 is critically required for the retention of T RM cells in the liver.
DISCUSSION
Several recent papers have identified populations of tissue-resident CD69
+ antigen-specific memory cells in the liver that patrol the sinusoids (5, 9, 10) . A critical question then is: How can an intravascular population in the circulation also be tissue-resident? Here, we show a critical role for ITGAL-and, by extension, the integrin LFA-1-in the migration of activated CD8 + T cells in the liver. We further show that LFA-1 is required for the retention of T RM cells in the liver. It is possible that these cells might occasionally exit the liver if . Data are pooled from three independent experiments and analyzed using an LMM including mouse as a random effect and the organ as the fixed effect. Bars show means and SD. **P < 0.01. they were to enter the hepatic venules, though it may be that these cells rapidly recirculate back to the liver because of the elevated expression of ICAM-1 in these tissues and the slow blood flow within this organ (14, 20) . Overall, though, our data support the hypothesis that it is the expression of high levels of LFA-1 on the surface of liver T RM cells that allows them to remain in the liver and patrol the hepatic sinusoids.
Our data further suggest that T RM populations in different tissues have different adhesion molecule requirements for tissue retention. In agreement with previous reports, we do not detect high levels of the integrin CD103 on the surface of our CD11a hi liver T RM cells (5, 10) . CD103 is highly expressed on epithelial T RM cells, such as those found in the skin and the gut, and has been shown to be required for T cell residence in the skin (2, 3, 13) . Its expression appears to be induced, even in vitro, by transforming growth factor- (TGF-) signaling (29) . In vivo, the level of CD103 expression increases progressively during skin T RM development as they migrate to the epidermis (30) . However, although CD103 may be critical for the residence of T RM cell populations in various epithelia, it is presumably dispensable for T RM populations that may remain exposed to the circulation. TGF- signaling has previously been shown to down-regulate LFA-1 expression, suggesting that these integrins may be reciprocally regulated (31, 32) .
Despite ICAM-1-LFA-1 interactions being considered canonical in the leukocyte adhesion cascade, their role in liver residence has been unclear. Whereas ICAM-1 has been suggested to have a role in the retention of naïve and activated cells in the liver (16, 20, 33) , antibody blockade with -LFA-1 antibodies was not found to inhibit the accumulation of activated CD8 + T cells in the liver (14) . Moreover, LFA-1-deficient mice do not have abnormal numbers of conventional T cells in the liver (17) . Our data resolve many of these contradictory observations. As with previous studies, we did not see any effect of antibody blockade on retention of activated effector cells to the liver, only a defect in migration. Our data also explain why previous studies missed a role of LFA-1 in CD8 + T cell migration to the liver, because LFA-1 is only absolutely required for the retention of the T RM phenotype (C) and (F) were analyzed using LMMs with mouse as a random effect and organ as the fixed effect. (E) was analyzed similarly to (C) but with genotype as the fixed effect. (G) was analyzed similarly to (C) but with experiment included as a random effect. **P < 0.01, ***P < 0.001, ****P < 0.0001.
cells, whereas other CD8 + T cells that are nonresident can transiently associate with the liver in the absence of LFA-1. Thus, previous studies of bulk CD8 + T cell populations were unable to detect the role of LFA-1 in this recently identified cell type.
Although our studies have focused on the role of LFA-1 in CD8 + T cell accumulation in the liver, we also find that this integrin is important for CD8 + T cell retention in the lung. We identified a population of cells in the lung that was CD11a (6, 24) . The absence of lung T RM cells is not unexpected because Plasmodium does not infect the lung, whereas LCMV only forms significant lung T RM populations after intratracheal infection (25) . In contrast to the liver, both CD69 + and CD69 − CD8 + T cells in the lung had a strong requirement for LFA-1 to be retained. This again highlights the different adhesion molecule requirements among diverse populations of CD8 + T cells in different organs. Previous studies have shown that LFA-1 is required for the retention of early effector cells in the lung (34), whereas another study has shown that LFA-1 is required for memory cell entry to the lung airways (35) . Our results extend these previous results in showing an important role for LFA-1 for the retention of vascular CD8 + T cell populations (as opposed to just those in the airways) at memory time points. Whereas liver sinusoids are characterized by slow blood flow, the flow is faster and cells experience more sheer stress in the lung (36) . Thus, LFA-1 may be universally required among CD8 + T cell populations in the lung to allow even transient associations with the endothelium.
In summary, we have found a previously unappreciated role for LFA-1 in the retention of CD8 + T cells in the liver and for the movement of these T cells within hepatic sinusoids. This motility is what appears to be important for the efficient surveillance of the liver and the identification of infected cells (9) . Crucially, because of the potential ability of the liver T RM cells to enter the circulation directly, the mechanism of retention in the liver appears different from that described for epithelial or mucosal T RM cells. Overall, our data suggest that the nature of tissue-resident CD8 + T cell populations may be even more diverse and complex than has previously been suggested.
MATERIALS AND METHODS
Details of standard immunological methods used in this study are given in Supplementary Materials and Methods.
Study design
The initial aim of the study was to determine the molecules involved in CD8 + T cell migration in the liver. Accordingly, experiments wherein we blocked candidate adhesion molecules and measured motility by intravital imaging were performed (Fig. 1) . Because the n for these experiments was determined by the number of cells, each mouse was considered an experimental repeat. No randomization or blinding was performed in these experiments; however, the hypothesis that blocking these molecules would affect migration was specified in advance, though the direction of the effect was not predicted. We therefore analyzed these experiments using a linear mixed model (LMM) approach, which accounts for variation between mice and experiments as random effects in addition to our fixed effects (movement parameters). These experiments suggested a role for LFA-1 in accumulation and migration, which we tested by cotransferring LFA-1-deficient and WT cells to mice and measuring migration and accumulation by intravital microscopy and flow cytometry. In these experiments, the hypothesis was specified in advance. Randomization and blinding could not be performed in these experiments because both the experimental and control groups were contained in the same mouse.
Having identified LFA-1 as a likely candidate for T cell migration and residence in the liver, we performed a series of controlled laboratory experiments to investigate this further (Figs. 2 to 7) . In these ) by flow cytometry for each organ and genotype, with (D) representative flow cytometry plots from individual mice and (E) summary data presented. Data in (B) to (E) were analyzed using LMMs including mouse as a random effect and organ and genotype as fixed effects; pairwise P values derived from the models are given. *P < 0.05, **P < 0.01, ***P < 0.001.
experiments, at least four mice per group were used in each individual experiment where the n was determined by the number of mice. Data presented were typically pooled from multiple experiments and were therefore usually analyzed using LMMs, which account for variation due to random effects (individual mice and experiments). Data from all mice studied are presented in the figures, and no outliers were excluded. In these experiments, the hypotheses were specified in advance. No randomization or blinding was performed; however, in many experiments, control and experimental groups (cells) were contained within the same animal.
Mice
C57BL/6.J mice, Rag1
−/− mice, OT-I mice (37), B2m −/− mice (38) , and uGFP mice (39) were bred in-house at the Australian National University (ANU). mT/mG mice (40) were purchased from the Jackson Laboratory and maintained at the ANU. ITGAL-C77F (Itgal −/− ) mice were identified in our ongoing ENU mutagenesis screens (22) . ITGAL-C77F mice were maintained on a C57BL/6.J background and crossed to an OT-I uGFP background, as required. All animal procedures were approved by the Animal Experimentation Ethics Committee of the ANU (protocol numbers A2013/12, A2014/62, and A2015/76).
Immunizations
Mice were immunized intravenously with 5 × 10 4 P. berghei CS 5M sporozoites expressing mCherry (23) dissected by hand from the salivary glands of Anopheles stephensi mosquitoes. Mice were then treated with 0.6 mg of choloroquine intraperitoneally daily for 10 days to prevent the development of blood stage infection. LCMV Armstrong was delivered intraperitoneally at a dose of 2 × 10 5 plaque-forming units (PFU) per mouse.
Antibody blockade
The following antibodies were injected intravenously 2 hours before transfer of activated OT-I CD8 (14)], and rat IgG2b isotype control (clone LTF2; BioXCell; 50 g per mouse).
Multiphoton microscopy
Mice were prepared for multiphoton microscopy essentially as described in Supplementary Materials and Methods (41) . Imaging was performed using a FluoView FVMPE-RS multiphoton microscope system (Olympus) equipped with an XLPLN25XWMP2 objective (25×; numerical aperture, 1.05; water immersion; 2-mm working distance). Images were acquired using FV30 software (Olympus) and exported to Imaris (Bitplane) for downstream processing, as described in Supplementary Materials and Methods. Movies were annotated and prepared for display using Adobe After Effects (Adobe).
Statistical analysis
Details of statistical analysis for each experiment are given in the relevant figure legend.  2 tests, t tests, Mann-Whitney U tests, and oneway analyses of variance (ANOVAs) were performed using Prism 6 (GraphPad). Where data were pooled from multiple experiments, multilevel analyses were performed using an LMM in GenStat (VSNi). LMMs are regression analysis models containing both fixed and random effects, with fixed effects being the variable/treatment under examination, whereas random effects are unintended factors that may influence the variable being measured. If significance was found from running an LMM, pairwise comparisons of the least significant differences of means were undertaken to determine at which level interactions were occurring. Statistical significance was assumed if the P value was <0.05 for a tested difference (ns, not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
SUPPLEMENTARY MATERIALS
immunology.sciencemag.org/cgi/content/full/2/9/eaaj1996/DC1 Materials and Methods Fig. S1 . CD44, VCAM-1, and 2-microglobulin are not required for CD8 + T cell motility in the liver. 
